ABVC BioPharma Inc logo

ABVC BioPharma Inc

$ 0.91 +0.1031 (+12.72%) 10:08 PM EST
P/E:
At Loss
P/B:
3.16
Market Cap:
$ 29.81M
Enterprise V:
$ 29.68M
Volume:
96.78K
Avg Vol (2M):
124.02K
Volume:
96.78K
Market Cap $:
29.81M
PE Ratio:
At Loss
Avg Vol (2-Month):
124.02K
Enterprise Value $:
29.68M
PB Ratio:
3.16
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
ABVC BioPharma is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Name Current Vs Industry Vs History
Cash-To-Debt 1.04
Equity-to-Asset 0.68
Debt-to-Equity 0.31
Debt-to-EBITDA -0.18
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.09
Distress
Grey
Safe
Beneish M-Score -2.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -9.7
3-Year EPS without NRI Growth Rate -12.3
3-Year FCF Growth Rate -79
Name Current Vs Industry Vs History
5-Day RSI 59.32
9-Day RSI 52.29
14-Day RSI 51.41
6-1 Month Momentum % -63.14
12-1 Month Momentum % -65.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.68
Quick Ratio 2.68
Cash Ratio 0.82
Days Inventory 919.52
Days Sales Outstanding 401.5
Days Payable 215.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -34.5

Financials (Next Earnings Date:2022-11-15 Est.)

ABVC's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ABVC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.4
EPS (TTM) ($) -0.64
Beta 1.03
Volatility % 97.64
14-Day RSI 51.41
14-Day ATR ($) 0.116009
20-Day SMA ($) 0.95223
12-1 Month Momentum % -65.14
52-Week Range ($) 0.5 - 11.69
Shares Outstanding (Mil) 32.63

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ABVC BioPharma Inc Filings

Document Form Filing Date
No Filing Data

ABVC BioPharma Inc Analysis

Share your research

Headlines

See More
No news.